ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Recombinant Anti-CD14 Antibody [rLPSR/2408] (CF®488A) (A354429)

Recombinant mouse monoclonal [rLPSR/2408] antibody to CD14 (CF®488A) for IHC and IHC-P .

Alternative Formats and ConjugatesAlternative Formats

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 6-9 business days.
Name
Anti-CD14 Antibody [rLPSR/2408] (CF®488A)
Description
Recombinant mouse monoclonal [rLPSR/2408] antibody to CD14 (CF®488A).
Applications
IHC, IHC-P
Positive Control
A549, THP-1 cells and human monocytes or lymph node and tonsil tissue.
Reactivity
Human
Immunogen
Recombinant fragment of human CD14 protein corresponding to approximately amino acids 25-148 (exact sequence is proprietary).
Host
Mouse
Clonality
Monoclonal
Clone ID
rLPSR/2408
Isotype
IgG1
Light Chains
kappa
Conjugate

CF®488A

Concentration
0.1 mg/mL
Predicted MW
55 kDa
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline with 0.1% BSA and 0.05% Sodium Azide.
Storage
Shipped and stored at +4°C. This product is also photosensitive and should be protected from light. Should this product contain a precipitate we recommend microcentrifugation before use. This CF® conjugated antibody is guaranteed for 2 years from data of receipt when stored correctly.
Synonyms
Monocyte differentiation antigen CD14, My23 antigen, Myeloid cell-specific leucine-rich glycoprotein
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Recombinant Anti-CD14 Antibody [rLPSR/2408] (CF®488A) (A354429)? Please let us know so that we can list the citation on this page.

Alternative products to Anti-CD14 Antibody [rLPSR/2408] (CF®488A) (A354429)

Proteins predicted to interact with CD14

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.5% Relevancy Score
99.2% Relevancy Score
99.1% Relevancy Score
97.7% Relevancy Score
93.5% Relevancy Score
81.7% Relevancy Score
80.5% Relevancy Score
80.3% Relevancy Score
76.7% Relevancy Score